These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20415562)

  • 1. Role of genetic variation in the cannabinoid type 1 receptor gene (CNR1) in the pathophysiology of human obesity.
    Schleinitz D; Carmienke S; Böttcher Y; Tönjes A; Berndt J; Klöting N; Enigk B; Müller I; Dietrich K; Breitfeld J; Scholz GH; Engeli S; Stumvoll M; Blüher M; Kovacs P
    Pharmacogenomics; 2010 May; 11(5):693-702. PubMed ID: 20415562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipose tissue expression and genetic variants of the bone morphogenetic protein receptor 1A gene (BMPR1A) are associated with human obesity.
    Böttcher Y; Unbehauen H; Klöting N; Ruschke K; Körner A; Schleinitz D; Tönjes A; Enigk B; Wolf S; Dietrich K; Koriath M; Scholz GH; Tseng YH; Dietrich A; Schön MR; Kiess W; Stumvoll M; Blüher M; Kovacs P
    Diabetes; 2009 Sep; 58(9):2119-28. PubMed ID: 19502417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced cannabinoid receptor 1 protein in subcutaneous adipose tissue of obese.
    Bennetzen MF; Nielsen TS; Paulsen SK; Bendix J; Fisker S; Jessen N; Lund S; Richelsen B; Pedersen SB
    Eur J Clin Invest; 2010 Feb; 40(2):121-6. PubMed ID: 20039929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of genetic variation in the human fatty acid synthase gene (FASN) on obesity and fat depot-specific mRNA expression.
    Schleinitz D; Klöting N; Körner A; Berndt J; Reichenbächer M; Tönjes A; Ruschke K; Böttcher Y; Dietrich K; Enigk B; Filz M; Schön MR; Jenkner J; Kiess W; Stumvoll M; Blüher M; Kovacs P
    Obesity (Silver Spring); 2010 Jun; 18(6):1218-25. PubMed ID: 19876008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and evolutionary analyses of the human bone morphogenetic protein receptor 2 (BMPR2) in the pathophysiology of obesity.
    Schleinitz D; Klöting N; Böttcher Y; Wolf S; Dietrich K; Tönjes A; Breitfeld J; Enigk B; Halbritter J; Körner A; Schön MR; Jenkner J; Tseng YH; Lohmann T; Dressler M; Stumvoll M; Blüher M; Kovacs P
    PLoS One; 2011 Feb; 6(2):e16155. PubMed ID: 21311592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in the endocannabinoid receptor 1 in relation to fat mass distribution.
    Frost M; Nielsen TL; Wraae K; Hagen C; Piters E; Beckers S; De Freitas F; Brixen K; Van Hul W; Andersen M
    Eur J Endocrinol; 2010 Sep; 163(3):407-12. PubMed ID: 20587580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants in the CNR1 and the FAAH genes and adiposity traits in the community.
    Lieb W; Manning AK; Florez JC; Dupuis J; Cupples LA; McAteer JB; Vasan RS; Hoffmann U; O'Donnell CJ; Meigs JB; Fox CS
    Obesity (Silver Spring); 2009 Apr; 17(4):755-60. PubMed ID: 19165169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability in cannabinoid receptor genes is associated with psychiatric comorbidities in anorexia nervosa.
    González LM; García-Herráiz A; Mota-Zamorano S; Flores I; Albuquerque D; Gervasini G
    Eat Weight Disord; 2021 Dec; 26(8):2597-2606. PubMed ID: 33575982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations.
    Benzinou M; Chèvre JC; Ward KJ; Lecoeur C; Dina C; Lobbens S; Durand E; Delplanque J; Horber FF; Heude B; Balkau B; Borch-Johnsen K; Jørgensen T; Hansen T; Pedersen O; Meyre D; Froguel P
    Hum Mol Genet; 2008 Jul; 17(13):1916-21. PubMed ID: 18375449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The FTO obesity gene. Genotyping and gene expression analysis in morbidly obese patients.
    Zabena C; González-Sánchez JL; Martínez-Larrad MT; Torres-García A; Alvarez-Fernández-Represa J; Corbatón-Anchuelo A; Pérez-Barba M; Serrano-Ríos M
    Obes Surg; 2009 Jan; 19(1):87-95. PubMed ID: 18855084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No evidence for an involvement of variants in the cannabinoid receptor gene (CNR1) in obesity in German children and adolescents.
    Müller TD; Reichwald K; Wermter AK; Brönner G; Nguyen TT; Friedel S; Koberwitz K; Engeli S; Lichtner P; Meitinger T; Schäfer H; Hebebrand J; Hinney A
    Mol Genet Metab; 2007 Apr; 90(4):429-34. PubMed ID: 17292652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyses of IGFBP2 DNA methylation and mRNA expression in visceral and subcutaneous adipose tissues of obese subjects.
    Zhang X; Gu HF; Frystyk J; Efendic S; Brismar K; Thorell A
    Growth Horm IGF Res; 2019 Apr; 45():31-36. PubMed ID: 30921666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations of the human endocannabinoid system in two subcutaneous adipose tissue depots in lean subjects and in obese subjects before and after weight loss.
    Bennetzen MF; Wellner N; Ahmed SS; Ahmed SM; Diep TA; Hansen HS; Richelsen B; Pedersen SB
    Int J Obes (Lond); 2011 Nov; 35(11):1377-84. PubMed ID: 21326208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men.
    Peeters A; Beckers S; Mertens I; Van Hul W; Van Gaal L
    Endocrine; 2007 Apr; 31(2):138-41. PubMed ID: 17873324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression.
    Kovacs P; Geyer M; Berndt J; Klöting N; Graham TE; Böttcher Y; Enigk B; Tönjes A; Schleinitz D; Schön MR; Kahn BB; Blüher M; Stumvoll M
    Diabetes; 2007 Dec; 56(12):3095-100. PubMed ID: 17728376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of estrogen receptor gene polymorphisms and mRNA levels on obesity and lipolysis--a cohort study.
    Nilsson M; Dahlman I; Jiao H; Gustafsson JA; Arner P; Dahlman-Wright K
    BMC Med Genet; 2007 Dec; 8():73. PubMed ID: 18053221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
    Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of vitamin D receptor gene expression in visceral and subcutaneous adipose tissue in non-obese, obese, and morbidly obese subjects.
    Yuzbashian E; Asghari G; Hedayati M; Zarkesh M; Mirmiran P; Khalaj A
    J Steroid Biochem Mol Biol; 2019 Mar; 187():82-87. PubMed ID: 30412764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of dietary intake of fruit and green vegetables with PTEN and P53 mRNA gene expression in visceral and subcutaneous adipose tissues of obese and non-obese adults.
    Kadkhoda G; Zarkesh M; Saidpour A; Oghaz MH; Hedayati M; Khalaj A
    Gene; 2020 Apr; 733():144353. PubMed ID: 31978509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid CB1 receptor expression in relation to visceral adipose depots, endocannabinoid levels, microvascular damage, and the presence of the Cnr1 A3813G variant in humans.
    Bordicchia M; Battistoni I; Mancinelli L; Giannini E; Refi G; Minardi D; Muzzonigro G; Mazzucchelli R; Montironi R; Piscitelli F; Petrosino S; Dessì-Fulgheri P; Rappelli A; Di Marzo V; Sarzani R
    Metabolism; 2010 May; 59(5):734-41. PubMed ID: 19919870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.